secwatch.observer — SEC 8-K summary
======================================

Issuer:     Centessa Pharmaceuticals plc (CNTA)
CIK:        0001847903
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001847903-23-000107
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Centessa posts updated corporate presentation; no material new facts disclosed in filing
--------------------------------------------------------------------------------

- Updated corporate slide deck posted to Centessa website on June 9, 2023.
- Exhibit 99.1 contains only boilerplate disclaimers and a title slide; substantive content not available.
- No financial results, pipeline updates, or guidance changes included in the filing body.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847903/000184790323000107/0001847903-23-000107-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847903/000184790323000107/cnta-20230609.htm
  HTML page:      https://secwatch.observer/filing/0001847903-23-000107

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer